2019
1056 Incorporation of Obesity Management into the Care of Patients With Nonalcoholic Steatohepatitis: The Yale Fatty Liver Disease Model
Mankash M, Kelly M, Dean J, Duffy A, Mehal W, Do A. 1056 Incorporation of Obesity Management into the Care of Patients With Nonalcoholic Steatohepatitis: The Yale Fatty Liver Disease Model. The American Journal Of Gastroenterology 2019, 114: s599-s599. DOI: 10.14309/01.ajg.0000593756.22484.ae.Peer-Reviewed Original ResearchNonalcoholic fatty liver diseaseWeight loss medicationsNonalcoholic steatohepatitisBariatric surgeryWeight lossClinical characteristicsLiver diseaseObesity managementEffective treatmentDisease programsAverage age 55Meal replacement therapySurgical weight lossWeight loss optionsAlanine aminotransferase levelsChronic liver diseaseFatty liver diseaseObstructive sleep apneaManagement of patientsCare of patientsLimited efficacy dataClinical care modelsLiver disease modelAverage weight lossHepatology clinic
2006
Controversies in the treatment of gastroesophageal reflux and achalasia
Roberts K, Duffy A, Bell R. Controversies in the treatment of gastroesophageal reflux and achalasia. World Journal Of Gastroenterology 2006, 12: 3155-3161. PMID: 16718833, PMCID: PMC4087956, DOI: 10.3748/wjg.v12.i20.3155.Peer-Reviewed Original ResearchConceptsGastroesophageal reflux diseaseLaparoscopic antireflux surgeryTreatment optionsEffective treatmentPneumatic dilatationSurgical therapyEsophageal sphincterLaparoscopic surgeryTreatment of GERDObjective long-term resultsEffective non-surgical treatmentSecond treatment optionShorter hospital stayLaparoscopic Heller myotomyNon-surgical treatmentRisk of adenocarcinomaImportant treatment optionTreatment of achalasiaGold standardLong-term resultsNew treatment optionsExperienced laparoscopic surgeonsNon-invasive optionMinimal invasive surgeryPoor esophageal